Combination of HER2-targeted agents with immune checkpoint inhibitors in the treatment of HER2-positive breast cancer

.

Source: Expert Opinion on Biological Therapy - November 22, 2021 Category: Drugs & Pharmacology Authors: Ashley Matusz-Fisher Antoinette R. Tan Source Type: research